VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $6.27M invested in VistaGen Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$212K
2
+$140K
3
+$1.03K

Top Sellers

1
-$644K
2
-$51K
3
-$31.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.03M
2
$1.32M
3
$1.06M
4
$658K
5
$515K
6
$324K
7
$140K
8
$112K
9
$75K
10
$36K
11
$5K
12
$4K
13
–